Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine

Conditions:   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Influenzae Type bInterventions:   Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™);   Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™)Sponsor:   Sanofi Pasteur, a Sanofi CompanyRecruiting - verified April 2015

Source: ClinicalTrials.gov - April 23, 2015 Category: Research Source Type: clinical trials